FRONTIERS IN BIOSCIENCE;

DATA FORM FOR CANCER STAGING - THYROID GLAND





Form # 785-1-020 

CLIN PATH  DEFINITIONS
     PRIMARY TUMOR (T)

TX Primary tumor cannot be assessed

T0 No evidence of primary tumor

T1 Tumor 1 cm or less in greatest dimension limited to the thyroid

T2 Tumor more than 1 cm but not more than 4 cm

T3 Tumor more than 4 cm in greatest dimension limited to the thyroid

T4 Tumor of any size extending beyond the thyroid capsule
    LYMPH NODE (N)

NX Regional lymph nodes cannot be assessed

N0 No regional lymph node metastasis

N1 Regional lymph node metastasis

  N1a Metastasis in ipsilateral cervical lymph nodes

  N1b Metastasis in bilateral, midline, or contralateral cervical or mediastinal lymph nodes
    DISTANT METASTASIS (M)

MX Presence of distant metastasis cannot be assessed

M0 No distant metastasis

M1 Distant metastasis

Pathologic Stage by: M.D. Date:

CLIN PATH STAGE GROUPING
    Separate stage groupings are recommended for papillary and follicular, medullary, and undifferentiated
    PAPILLARY OR FOLLICULAR

Under 45 years

Stage I Any T Any N M0

Stage II Any T Any N M1
    45 years and over

Stage I T1 N0 M0

Stage II T2 N0 M0
      T3 N0 M0

Stage III T4 N0 M0
      Any T N1 M0

Stage IV Any T N1 M1
    MEDULLARY

Stage I T1 N0 M0

Stage II T2 N0 M0
      T3 N0 M0
      T4 N0 M0

Stage III Any T N1 M0

Stage IV Any T Any N M1
    UNDIFFERENTIATED

All cases are Stage IV

Stage IV Any T Any N Any M

Attending: M.D. Date:

THE FINAL STAGE GROUPING (CLINICAL & PATHOLOGICAL) IS THE RESPONSIBILITY OF THE ATTENDING PHYSICIAN.

Comments:

Patient Name: